Cargando…

Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone

Background and Objectives: Frostbite is a freezing injury that can lead to amputation. Current treatments include tissue rewarming followed by thrombolytic or vasodilators. Hyperbaric oxygen (HBO) therapy might decrease the rate of amputation by increasing cellular oxygen availability to the damaged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magnan, Marie-Anne, Gayet-Ageron, Angèle, Louge, Pierre, Champly, Frederic, Joffre, Thierry, Lovis, Christian, Pignel, Rodrigue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620371/ https://www.ncbi.nlm.nih.gov/pubmed/34833502 http://dx.doi.org/10.3390/medicina57111284

Ejemplares similares

Iloprost for the treatment of frostbite: a scoping review
por: Gauthier, Josianne, et al.
Publicado: (2023)

Use of fluorescence to visualize response to iloprost treatment for frostbite
por: MacLennan, Mira, et al.
Publicado: (2021)

Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series
por: Poole, Alexander, et al.
Publicado: (2021)

Effects of hyperbaric oxygen and iloprost on intestinal ischemia-reperfusion induced acute lung injury
por: Yilmaz, Yeliz, et al.
Publicado: (2019)

Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model
por: Bozok, Ş, et al.
Publicado: (2012)

Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009)

Iloprost for COVID-19-related vasculopathy
por: Moezinia, Carine J, et al.
Publicado: (2020)

Successful treatment of frostbite with hyperbaric oxygen treatment
por: Dwivedi, Deepak A., et al.
Publicado: (2015)

Iloprost modulates the immune response in systemic sclerosis
por: D'Amelio, Patrizia, et al.
Publicado: (2010)

Inhaled iloprost for the treatment of patient with Fontan circulation
por: Kim, Yong Hyun, et al.
Publicado: (2014)

Effectiveness of Iloprost in the Treatment of Bone Marrow Edema
por: Tosun, Hacı Bayram, et al.
Publicado: (2020)

Iloprost in COVID-19: The Rationale of Therapeutic Benefit
por: Faggioli, Paola Maria, et al.
Publicado: (2021)

The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels
por: Suna, Aydin, et al.
Publicado: (2017)

Inhaled iloprost can improve oxygenation and shunt fraction in severe COVID-19
por: Serbanescu-Kele Apor de Zalán, Christiaan M.C., et al.
Publicado: (2022)

The impact of nebulized epoprostenol and iloprost on hemoglobin oxygen affinity: an ex vivo experiment
por: Woyke, Simon, et al.
Publicado: (2022)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
por: Bixio, Riccardo, et al.
Publicado: (2022)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007)

Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009)

The Effect of Iloprost on Renal Function in Patients with Critical Limb Ischemia()
por: Ay, Yasin, et al.
Publicado: (2013)

User preference for a portable syringe pump for iloprost infusion
por: Laria, Antonella, et al.
Publicado: (2015)

Iloprost requires the Frizzled-9 receptor to prevent lung cancer
por: Sompel, Kayla, et al.
Publicado: (2022)

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022)

The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension
por: Nakayama, Kazuhiko, et al.
Publicado: (2018)

Successful treatment of jellyfish sting-induced severe digital ischemia with intravenous iloprost infusion
por: Lo, Arthur H., et al.
Publicado: (2016)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
por: Jain, Pritesh P, et al.
Publicado: (2014)

Effect of iloprost on the microcirculation and liver function after orthotopic liver transplantation
por: Klinzing, S, et al.
Publicado: (2008)

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients
por: Uyar, Mehtap Erkmen, et al.
Publicado: (2016)

Iloprost: Diarrhoea, rebound tachycardia and worsening of symptoms: 3 case reports
Publicado: (2020)

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021)

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
por: Yıldırım, Şükran
Publicado: (2023)

The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial
por: Choi, Hoon, et al.
Publicado: (2019)

Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
por: Loureiro, Maria José, et al.
Publicado: (2007)

Inhaled Iloprost for Patients With Precapillary Pulmonary Hypertension and Right-Side Heart Failure
por: Martischnig, Amadea M., et al.
Publicado: (2011)

Effects of inhaled iloprost on acute respiratory distress syndrome in prone and supine positions
por: Senturk, E, et al.
Publicado: (2009)

Combined Thenar and Hypothenar Hammer Syndromes and Raynaud's Phenomenon Successfully Treated with Iloprost
por: Ciapetti, Alessandro, et al.
Publicado: (2016)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
por: Wang, Lan, et al.
Publicado: (2017)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
por: Richter, Manuel J., et al.
Publicado: (2018)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tg1s3kcm0t3691s4lm6svkp0rs